Tissue plasminogen activator treatment of bilateral pulmonary emboli in a pediatric patient supported with a ventricular assist device

Bleeding and thrombosis are well‐known potential complications of VAD support. We present a pediatric patient who developed massive bilateral pulmonary emboli while on BiVAD support that was successfully treated with intravenous tPA and bridged to heart transplant.

Saved in:
Bibliographic Details
Published inPediatric transplantation Vol. 19; no. 7; pp. E160 - E164
Main Authors Godown, Justin, Dodd, Debra A., Doyle, Thomas P., Smith, Andrew H., Janssen, Dana, Mettler, Bret A.
Format Journal Article
LanguageEnglish
Published Denmark 01.11.2015
Subjects
Fibrinolytic Agents - therapeutic use
Heart Failure - complications
Heart Failure - therapy
Heart Transplantation
Heart-Assist Devices - adverse effects
Humans
Infant
Male
pediatric heart transplant
pulmonary embolism
Pulmonary Embolism - drug therapy
Pulmonary Embolism - etiology
Tissue Plasminogen Activator - therapeutic use
ventricular assist device
ventricular assist device
pulmonary embolism
pediatric heart transplant
Online AccessGet full text

Cover

More Information
Summary:Bleeding and thrombosis are well‐known potential complications of VAD support. We present a pediatric patient who developed massive bilateral pulmonary emboli while on BiVAD support that was successfully treated with intravenous tPA and bridged to heart transplant.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:1397-3142
1399-3046
DOI:10.1111/petr.12568